Reducing DMTA cycle times by 20% with our assay-ready spheroids

Lucero is a spin-off from Chalmers University of Technology and research done at Gothenburg University.

Through close collaboration with industry, we learned about the desperate need for more predictive in-vitro tools in early-stage drug discovery.

To make more accurate go/no-go decisions and reduce dependency on animal testing.

Since 2020, we’ve lived and breathed 3D culture.

We believe that making these models broadly accessible to drugdevelopers is one key to advancing how modern medicine is developed.

Ultimately, our mission is to provide a tool that helps drug developers dotheir jobs more effectively and to get life-saving medications to patientsfaster.